{
  "id": "cluster_1_doc3",
  "content": "Provider Update Memo (effective May 2023): Silver Pines Medical Group now requiring twin signatures for biologic therapy approvals following overutilization findings in dermatology department. Impact observed on claims processing timeline - average delay increased by 7 working days for immunomodulator cases.",
  "metadata": {
    "format": "insurance_memo"
  }
}